查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928624

一步法RT-qPCR試劑盒市場按類型、目標分子、試劑盒規格、應用和終端用戶，全球預測，2026-2032年

One Step RT-qPCR Kits Market by Type, Target Molecule, Kit Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，一步法 RT-qPCR 試劑盒市值將達到 10 億美元，到 2026 年將成長到 11 億美元，到 2032 年將達到 19.5 億美元，複合年成長率為 9.92%。

關鍵市場統計數據
基準年 2025 10億美元
預計年份：2026年 11億美元
預測年份 2032 19.5億美元
複合年成長率 (%) 9.92%

本書權威地介紹了一步法RT-qPCR試劑盒，說明了其技術目標、操作優勢以及這些試劑盒在實驗室中日益重要的作用。

一步法RT-qPCR試劑盒將逆轉錄和定量PCR結合在單一反應中，簡化了科學研究、臨床和工業實驗室中RNA標靶的定量工作流程。這些試劑盒旨在透過將兩個酶促反應步驟整合到一個最佳化的試劑系統中，最大限度地減少操作時間、降低污染風險並提高通量。酵素混合物、緩衝液化學和螢光檢測相容性的技術改進，已將一步法試劑盒的效用從緊急感染疾病診斷擴展到常規基因表現研究和品管檢測。

技術創新、監管壓力和供應鏈演變正在共同重塑一步法RT-qPCR的格局，並推動其在各實驗室的永續應用。

由於技術、監管和操作等多方面因素的共同作用，一步法RT-qPCR技術格局發生了翻天覆地的變化。酵素工程和多重探針化學的進步顯著提高了檢測的特異性和通量，使得複雜檢測組合的分析步驟得以簡化。同時，冷凍干預混液和無需儀器的製劑的出現降低了物流成本，實現了分散式檢查和遠端實驗室操作。

關稅環境變化對一步法RT-qPCR試劑盒相關人員的策略影響：對供應鏈結構、定價策略和區域製造地選擇的影響

近期貿易政策和關稅結構的變化給國際供應鏈上的製造商和買家帶來了新的考量。影響試劑、塑膠和進口設備的關稅調整正在改變到岸成本，並影響採購決策，促使供應商和買家重新評估籌資策略。為此，許多企業正在實現供應來源多元化、部分生產流程本地化，並調整庫存管理方式，以保護自身營運免受進口關稅波動的影響。

透過整合化學形式、應用需求、最終用戶檢驗需求、目標分子考量以及試劑盒形式物流，制定產品策略。

了解這種市場細分對於使產品設計、行銷和分銷策略與最終用戶需求和技術要求保持一致至關重要。在試劑盒類型中，市場可區分基於染料和基於探針的化學方法。基於染料的系統，例如 EvaGreen 和 SYBR Green，提供經濟高效的檢測，適用於廣泛的表達譜分析。同時，基於探針的形式，例如 Molecular Beacon、Scorpions 和 TaqMan 探針，具有更高的特異性和多重檢測能力，是診斷和靶向檢測的首選。應用主導的需求涵蓋癌症篩檢、藥物研發、環境檢測、食品安全、基因表現分析和傳染病檢查等領域，每個領域都有不同的性能優先級，從靈敏度和定量準確性到法規遵從性和樣本處理能力。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太市場的產品設計、商業化和支援策略。

區域趨勢將深刻影響產品設計、分銷和客戶參與策略。在美洲，強大的臨床和製藥業對可靠的試劑、監管文件和值得信賴的供應鏈有著極高的要求，因此，能夠證明產品性能檢驗且具備可擴展生產能力的供應商更受青睞。在歐洲、中東和非洲，不同的管理體制和檢查室基礎設施要求供應商提供靈活的產品系列和區域性支援模式，以應對不斷變化的市場接受度和公共衛生優先事項。在亞太地區，對研究基礎設施的快速投資、不斷擴大的臨床試驗能力以及區域內生產能力的提升，為全球和本地供應商與學術界和產業界實驗室合作，推進檢驗和本地化工作創造了機會。

決定一步法RT-qPCR試劑盒市場中企業長期成功的關鍵競爭要素與經營模式選擇

在一步法RT-qPCR試劑盒領域，競爭優勢的建構依賴技術差異化、監管應對力、供應鏈可靠性和客戶支援能力的綜合考量。主要企業通常會投資於酵素製劑、專有探針化學以及確保批次間一致性的完善品質系統的研究。與儀器製造商、契約製造製造商和分銷網路建立策略聯盟，有助於拓展市場並緩解產能瓶頸。

就產品創新、供應鏈韌性、法規遵循和客戶參與等方面提出切實可行的建議，以加速產品推廣和商業性成功。

產業領導者應採取多管齊下的策略，將技術創新、供應鏈韌性和以客戶為中心的商業化結合在一起。應優先開發穩健的酵素系統和探針化學方法，在確保靈敏度、特異性和多重檢測能力的同時，確保與常用qPCR儀器的兼容性。此外，還應考慮投資開發其他試劑盒形式，例如冷凍干預混液，以解決物流限制並擴大市場進入。

為確保可行性和準確性，我們採用了一種穩健的混合方法研究方法，該方法整合了對關鍵相關人員的訪談、對二手文獻的三角驗證以及實驗室性能檢驗。

本分析的調查方法結合了初步定性研究結果、二手文獻綜述以及與實驗室性能數據的交叉檢驗。主要資料來源包括對學術界、臨床和工業實驗室主任、採購負責人以及技術應用專家的結構化訪談，以了解決策促進因素和檢驗標準。二級資訊來源包括同行評審文獻、監管指導文件以及已發表的技術白皮書，這些資料闡述了酶技術、探針化學和試劑盒形式的相關背景。

本文概述了決定一步法RT-qPCR領域未來成功的策略要務、技術重點和營運槓桿。

總之，一步法RT-qPCR試劑盒在現代分子工作流程中發揮至關重要的作用，能夠有效可靠地進行RNA定量，並適用於廣泛的應用。酵素化學、探針設計和試劑盒形式的創新正在拓展其應用範圍，使其從科研環境擴展到受監管的臨床和工業領域。同時，供應鏈和法規環境的變化趨勢也持續影響其應用路徑。那些能夠將產品開發與特定應用需求、區域營運實務和嚴格的檢驗要求結合的相關人員，將更有利於把握持續的市場需求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依類型分類的一步法RT-qPCR試劑盒市場

  • 染料
    • 常綠
    • SYBR Green
  • 探針基座
    • 分子信標
    • 蠍
    • TaqMan探針

9. Target Molecule 的一步法 RT-qPCR 試劑盒市場

  • 細菌
  • DNA病毒
  • 微型RNA
  • RNA病毒

10. 依試劑盒類型分類的一步法RT-qPCR試劑盒市場

  • 液體
  • 冷凍乾燥
  • 母帶混音

第11章：依應用分類的一步法RT-qPCR試劑盒市場

  • 癌症篩檢
  • 藥物發現
  • 環境檢查
  • 食品檢驗
  • 基因表現分析
  • 感染疾病

第12章：依最終用戶分類的一步法RT-qPCR試劑盒市場

  • 學術機構
  • 臨床診斷
  • 製藥和生物技術公司
  • 研究所

13. 依地區分類的一步法RT-qPCR試劑盒市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依組別分類的一步法RT-qPCR試劑盒市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國一步法RT-qPCR試劑盒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國一步法RT-qPCR試劑盒市場

第17章：中國一步法RT-qPCR試劑盒市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Applied Biological Materials Inc.
  • Avantor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Fortis Life Sciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Quantabio, Inc.
  • Roche Holding AG
  • Solis BioDyne, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TIANGEN Biotech（Beijing）Co., Ltd.
  • Zymo Research Corporation
Product Code: MRR-92740D85F074

The One Step RT-qPCR Kits Market was valued at USD 1.00 billion in 2025 and is projected to grow to USD 1.10 billion in 2026, with a CAGR of 9.92%, reaching USD 1.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.00 billion
Estimated Year [2026] USD 1.10 billion
Forecast Year [2032] USD 1.95 billion
CAGR (%) 9.92%

An authoritative introduction to one-step RT-qPCR kits covering technological purpose operational advantages and the expanding role these kits play across laboratories

One-step RT-qPCR kits combine reverse transcription and quantitative PCR in a single reaction, streamlining workflows that quantify RNA targets across research, clinical, and industrial laboratories. These kits are designed to minimize hands-on time, reduce contamination risk, and improve throughput by collapsing two enzymatic steps into a single, optimized reagent system. Technological refinements in enzyme blends, buffer chemistries, and fluorescence detection compatibility have expanded the usability of one-step kits beyond emergency infectious disease diagnostics into routine gene expression studies and quality control assays.

Early adopters appreciated the operational simplicity and reproducibility benefits, while later generations emphasized robustness across sample types and instrument platforms. As laboratories balance demands for speed and analytical sensitivity, one-step kits increasingly serve as a backbone reagent for high-throughput screening and targeted testing. Moreover, integration with lyophilized formats and master mixes addresses logistical constraints such as cold-chain dependency and batch-to-batch variability.

Transitioning from single-use demonstration deployments to standard lab protocols requires careful validation, but the overall trend is clear: one-step RT-qPCR kits are enabling laboratories to achieve faster turnaround, reproducible quantification, and simplified workflow management without sacrificing analytical rigor.

How converging technological innovation regulatory pressure and supply chain evolution are reshaping the one-step RT-qPCR landscape and driving sustainable adoption across labs

The one-step RT-qPCR landscape has undergone transformative shifts driven by converging technological, regulatory, and operational forces. Advances in enzyme engineering and multiplex probe chemistries have significantly enhanced assay specificity and throughput, enabling complex panels to be run with fewer manipulations. Meanwhile, the emergence of lyophilized master mixes and instrument-agnostic formulations has reduced logistical friction, enabling decentralized testing and remote laboratory operations.

Regulatory expectations and quality management practices have pushed suppliers to provide more robust documentation and lot-to-lot consistency, which in turn fosters broader adoption among clinical and pharmaceutical users who demand validated reagents. The pandemic response accelerated investment in rapid assay development and supply chain resilience; this momentum persisted as manufacturers focused on modular kit designs and global distribution strategies. At the same time, increasing demand for multiplex and high-sensitivity applications has steered innovation toward hybrid probe technologies and optimized buffer systems that maintain performance across diverse sample matrices.

Collectively, these shifts reflect a maturation of the market: vendors are balancing performance innovation with supply reliability and practical usability, while end users seek solutions that reduce complexity and integrate smoothly into existing laboratory ecosystems.

Strategic implications of evolving tariff landscapes on supply chain configuration pricing strategies and regional manufacturing choices for one-step RT-qPCR kit stakeholders

Recent changes in trade policy and tariff structures have introduced new considerations for manufacturers and purchasers operating across international supply chains. Tariff adjustments affecting reagents, plasticware, and imported instrumentation can alter landed costs and influence procurement decisions, prompting both suppliers and buyers to reassess sourcing strategies. In response, many organizations are diversifying supplier bases, localizing certain manufacturing steps, and reconfiguring inventory practices to insulate operations from volatility in import duties.

Procurement teams are increasingly incorporating tariff sensitivity into vendor selection criteria, evaluating not only price and performance but also the geographic footprint of suppliers and their ability to absorb or mitigate duty impacts. For manufacturers, shifting tariffs can affect margin structures and may incentivize establishing regional distribution centers or contract manufacturing partnerships to preserve competitiveness. At the same time, downstream users-such as clinical labs and research institutions-are adjusting budgetary planning to account for potential price variability and longer lead times associated with cross-border logistics.

Ultimately, the cumulative impact of tariffs is less about single-point cost increases and more about the strategic reorientation of supply chains, pricing models, and regional manufacturing footprints to maintain product availability and cost-effectiveness under evolving trade regimes.

Integrated segmentation analysis linking chemistry formats application requirements end-user validation needs target molecule considerations and kit format logistics to inform product strategy

Understanding segmentation is essential to aligning product design, marketing, and distribution strategies with end-user needs and technical requirements. Within kit type, the market differentiates between dye-based and probe-based chemistries; dye-based systems, including EvaGreen and SYBR Green, offer cost-effective detection suitable for broad expression profiling, whereas probe-based formats such as Molecular Beacon, Scorpions, and TaqMan probes provide higher specificity and multiplexing capability, making them preferable for diagnostics and targeted assays. Application-driven demand spans cancer screening, drug discovery, environmental testing, food safety, gene expression profiling, and infectious disease testing, each with distinct performance priorities ranging from sensitivity and quantitation accuracy to regulatory compliance and sample throughput.

End-user segmentation reveals diverse validation requirements and purchasing behaviors: academic institutes and research institutes prioritize flexibility and open-system compatibility, clinical diagnostics entities emphasize certified performance and regulatory traceability, while pharmaceutical and biotech companies demand batch consistency, scalable supply, and documentation suitable for regulated workflows. Target molecule considerations-bacteria, DNA viruses, microRNA, and RNA viruses-drive assay design choices around extraction compatibility, reverse transcription efficiency, and probe selection. Kit format options, including liquid, lyophilized, and master mix preparations, influence logistics, shelf life, and ease of deployment; lyophilized formats reduce cold-chain dependence and are attractive for field or decentralized testing, while master mixes support high-throughput laboratory automation.

By mapping these segment layers together, stakeholders can prioritize product features that align with specific application needs and end-user constraints, thereby improving adoption rates and commercial precision.

Regional dynamics shaping product design commercialization and support strategies across the Americas Europe Middle East Africa and Asia-Pacific markets

Regional dynamics profoundly shape product design, distribution, and customer engagement strategies. In the Americas, strong clinical and pharmaceutical sectors demand high-assurance reagents, regulatory documentation, and reliable supply chains; this market favors suppliers who can demonstrate validated performance and scalable manufacturing. The Europe, Middle East & Africa region features a heterogeneous set of regulatory regimes and laboratory infrastructures, which necessitates flexible product portfolios and localized support models to address variable adoption curves and public health priorities. In Asia-Pacific, rapid investment in research infrastructure, expanding clinical testing capacity, and an increasing number of regional manufacturing capabilities create opportunities for both global and local suppliers to partner with academic and industrial laboratories on validation and localization efforts.

Each region also differs in logistics constraints, procurement practices, and funding cycles; suppliers that tailor their commercial approach-whether through regional warehousing, strategic distributor partnerships, or localized technical services-tend to accelerate uptake. Moreover, regional public health initiatives and research funding priorities influence demand patterns for specific applications such as infectious disease surveillance or cancer screening programs. Adapting product formats, documentation, and go-to-market strategy to regional expectations will be pivotal for suppliers aiming to sustain growth and build resilient customer relationships across diverse geographies.

Key competitive imperatives and business model choices that determine long-term success for companies operating in the one-step RT-qPCR kit market

Competitive positioning in the one-step RT-qPCR kit arena rests on a blend of technical differentiation, regulatory readiness, supply chain reliability, and customer support capability. Leading companies typically invest in enzyme formulation research, proprietary probe chemistries, and robust quality systems to deliver consistent lot-to-lot performance. Strategic partnerships with instrument manufacturers, contract manufacturers, and distribution networks extend market reach while mitigating capacity constraints.

Companies that excel in this space often emphasize value-added services such as protocol optimization, on-site validation support, and documentation packages tailored for clinical and pharmaceutical end users. Others focus on cost leadership through streamlined manufacturing and alternative formats like lyophilized reagents to target resource-limited settings. Intellectual property around enzyme blends and probe designs can create barriers to entry, but modular licensing and collaborative development agreements remain viable paths for smaller innovators to scale.

Finally, reputation for supply continuity and transparent communication during supply disruptions is a competitive advantage; purchasers prioritize vendors that can demonstrate contingency planning, flexible production capacity, and clear timelines for order fulfillment. The interplay between innovation and operational excellence ultimately determines which companies sustain long-term relationships with demanding end users.

Actionable recommendations for product innovation supply chain resilience regulatory preparedness and customer engagement to accelerate adoption and commercial success

Industry leaders should adopt a multipronged approach that combines technical innovation with supply chain resilience and customer-centric commercialization. Prioritize development of robust enzyme systems and probe chemistries that balance sensitivity, specificity, and multiplex capability while ensuring compatibility across commonly used qPCR instruments. Invest in alternative kit formats, such as lyophilized master mixes, to address logistical constraints and broaden market accessibility.

Concurrently, strengthen regional manufacturing and distribution footprints to mitigate tariff exposure and reduce lead times. Establish transparent contingency plans with contract manufacturers and strategic distributors to ensure continuity during demand surges or trade disruptions. Enhance regulatory readiness by providing comprehensive documentation, validation data, and application notes tailored to clinical and pharmaceutical customers. Foster partnerships with clinical laboratories and research institutions to co-develop assays that address real-world sample matrices and workflow constraints.

Finally, adopt outcome-oriented commercial models that include technical support, training, and validation services, thereby lowering adoption barriers and demonstrating value beyond the reagent. These steps will help organizations translate technical capability into sustainable market advantages and resilient customer relationships.

Robust mixed-methods research approach integrating primary stakeholder interviews secondary literature triangulation and laboratory performance validation to ensure actionable accuracy

The research methodology underpinning this analysis combines primary qualitative insights, secondary literature synthesis, and cross-validation with laboratory performance data. Primary inputs included structured interviews with laboratory directors, procurement leads, and technical application specialists across academic, clinical, and industrial settings to capture decision drivers and validation criteria. Secondary sources encompassed peer-reviewed literature, regulatory guidance documents, and publicly available technical white papers that contextualize enzyme technologies, probe chemistries, and kit formats.

Analytical steps involved mapping segmentation layers to observed adoption patterns, assessing the operational implications of kit formats, and evaluating the effects of trade and logistics on procurement behavior. Performance characteristics cited in the report were cross-referenced with manufacturer technical sheets and independent validation studies to ensure factual accuracy and reproducibility of conclusions. Sensitivity checks were applied when interpreting stakeholder perspectives to reduce bias and to highlight diverging priorities among end users.

This mixed-methods approach ensures that recommendations are grounded in both technical reality and market behavior, providing a pragmatic foundation for strategic decision-making and product development planning.

Concluding synthesis highlighting the strategic imperatives technical priorities and operational levers that will determine future success in the one-step RT-qPCR landscape

In conclusion, one-step RT-qPCR kits occupy a pivotal role in modern molecular workflows by delivering streamlined, reliable RNA quantification suitable for a broad array of applications. Innovations in enzyme chemistry, probe design, and kit formats have expanded applicability from research settings into regulated clinical and industrial environments, while supply chain and regulatory dynamics continue to influence adoption pathways. Stakeholders who align product development with application-specific requirements, regional operational realities, and rigorous validation expectations will be best positioned to capture sustained demand.

The evolving landscape favors suppliers that combine technical excellence with operational resilience and customer-focused services. By addressing logistical constraints through format innovation and by enhancing regional support capabilities, manufacturers can reduce adoption barriers and foster long-term partnerships with demanding end users. Strategic attention to regulatory documentation and robust validation support will further differentiate vendors in increasingly quality-driven procurement environments.

Taken together, these elements form the basis of a pragmatic roadmap for organizations seeking to strengthen their presence in the one-step RT-qPCR space and to translate scientific capability into commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. One Step RT-qPCR Kits Market, by Type

  • 8.1. Dye Based
    • 8.1.1. EvaGreen
    • 8.1.2. SYBR Green
  • 8.2. Probe Based
    • 8.2.1. Molecular Beacon
    • 8.2.2. Scorpions
    • 8.2.3. TaqMan Probe

9. One Step RT-qPCR Kits Market, by Target Molecule

  • 9.1. Bacteria
  • 9.2. DNA Viruses
  • 9.3. MicroRNA
  • 9.4. RNA Viruses

10. One Step RT-qPCR Kits Market, by Kit Format

  • 10.1. Liquid
  • 10.2. Lyophilized
  • 10.3. Master Mix

11. One Step RT-qPCR Kits Market, by Application

  • 11.1. Cancer Screening
  • 11.2. Drug Discovery
  • 11.3. Environmental Testing
  • 11.4. Food Testing
  • 11.5. Gene Expression Profiling
  • 11.6. Infectious Disease

12. One Step RT-qPCR Kits Market, by End User

  • 12.1. Academic Institutes
  • 12.2. Clinical Diagnostics
  • 12.3. Pharmaceutical & Biotech Companies
  • 12.4. Research Institutes

13. One Step RT-qPCR Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. One Step RT-qPCR Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. One Step RT-qPCR Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States One Step RT-qPCR Kits Market

17. China One Step RT-qPCR Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Applied Biological Materials Inc.
  • 18.6. Avantor, Inc.
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Fortis Life Sciences, Inc.
  • 18.9. Merck KGaA
  • 18.10. New England Biolabs, Inc.
  • 18.11. Promega Corporation
  • 18.12. QIAGEN N.V.
  • 18.13. Quantabio, Inc.
  • 18.14. Roche Holding AG
  • 18.15. Solis BioDyne, Inc.
  • 18.16. Takara Bio Inc.
  • 18.17. Thermo Fisher Scientific Inc.
  • 18.18. TIANGEN Biotech (Beijing) Co., Ltd.
  • 18.19. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ONE STEP RT-QPCR KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ONE STEP RT-QPCR KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY EVAGREEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY EVAGREEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY EVAGREEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SYBR GREEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SYBR GREEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SYBR GREEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MOLECULAR BEACON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MOLECULAR BEACON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MOLECULAR BEACON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SCORPIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SCORPIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SCORPIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TAQMAN PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TAQMAN PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TAQMAN PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DNA VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DNA VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DNA VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MICRORNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MICRORNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MICRORNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RNA VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RNA VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RNA VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LYOPHILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LYOPHILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MASTER MIX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MASTER MIX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MASTER MIX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY FOOD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY FOOD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY FOOD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)